Examining the microglial TSPO phenotype in Alzheimer’s disease
Examining the microglial TSPO phenotype in Alzheimer’s disease
Background: neuroinflammation is a key pathological feature of Alzheimer’s disease (AD), with microglia being the main inflammatory cell type in the CNS. In order to examine these cells in vivo, PET ligands targeting the microglial translocator protein (TSPO) have been developed. However, it remains unclear the specific target of these ligands, whether this is all microglia or a subset of cells. We aim to elucidate this by identifying the microglial phenotype most associated with TSPO in humans.
Method: human post-mortem sections of temporal lobe (TL) and cerebellum (Cb) from cases classified by Braak stage (0-II, III-IV, V-VI; each n = 10) were immunostained for pan-Aß, pTau, and microglial markers TSPO, Iba1 and HLA-DR with protein load quantified. Double immunofluorescent staining was performed with TSPO and microglial markers HLA-DR and CD68 with positive cells counted.
Result: TL showed an increase in Aβ (P<0.0001), pTau (P<0.0001) and TSPO (P<0.0001) protein load, but not Iba1 or HLA-DR, with progressing Braak stage. Aβ (P = 0.0008) and Iba1 (P = 0.012) load increased in the Cb, but not pTau, TSPO or HLA-DR. Of note, TSPO load in TL was associated with pTau. In both areas, no difference was found in number of HLA+ or CD68+ cells, though TL TSPO+ cell number increased significantly (P = 0.0347). There was no difference in the number of HLA-DR+/TSPO+ or CD68+/TSPO+ cells with progressing Braak stage. However, significantly more CD68+/TSPO+ than HLA-DR+/TSPO+ cells were detected in both the TL (P<0.0001) and Cb (P = 0.009) regions.
Conclusion: the results suggest that TSPO expression is related to late stage disease (pTau) and microglial phagocytosis (CD68), a function we have previously identified associated with the presence of dementia, cognitive decline and tau pathology. Further additional analysis with other microglial markers is currently ongoing.
Garland, Emma F.
b59c66f2-ac4c-4d8d-823d-687769deccce
Kulagowska, Laura
97aa0e3a-d4e5-4137-a845-850b2d2f5933
Scott, Thomas
651073ff-87d8-42a9-a25d-c2a663fcb449
Antony, Henrike
34d46cf2-833a-4272-82e2-41e082fa8c68
Bottlaender, Michel
7ec76930-cf42-4f7b-8801-fbb3789eabed
Nicoll, James A.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
25 December 2023
Garland, Emma F.
b59c66f2-ac4c-4d8d-823d-687769deccce
Kulagowska, Laura
97aa0e3a-d4e5-4137-a845-850b2d2f5933
Scott, Thomas
651073ff-87d8-42a9-a25d-c2a663fcb449
Antony, Henrike
34d46cf2-833a-4272-82e2-41e082fa8c68
Bottlaender, Michel
7ec76930-cf42-4f7b-8801-fbb3789eabed
Nicoll, James A.
88c0685f-000e-4eb7-8f72-f36b4985e8ed
Boche, Delphine
bdcca10e-6302-4dd0-919f-67218f7e0d61
Garland, Emma F., Kulagowska, Laura and Scott, Thomas
,
et al.
(2023)
Examining the microglial TSPO phenotype in Alzheimer’s disease.
Alzheimer's & Dementia, 19 (S13), [e073305].
(doi:10.1002/alz.073305).
Record type:
Meeting abstract
Abstract
Background: neuroinflammation is a key pathological feature of Alzheimer’s disease (AD), with microglia being the main inflammatory cell type in the CNS. In order to examine these cells in vivo, PET ligands targeting the microglial translocator protein (TSPO) have been developed. However, it remains unclear the specific target of these ligands, whether this is all microglia or a subset of cells. We aim to elucidate this by identifying the microglial phenotype most associated with TSPO in humans.
Method: human post-mortem sections of temporal lobe (TL) and cerebellum (Cb) from cases classified by Braak stage (0-II, III-IV, V-VI; each n = 10) were immunostained for pan-Aß, pTau, and microglial markers TSPO, Iba1 and HLA-DR with protein load quantified. Double immunofluorescent staining was performed with TSPO and microglial markers HLA-DR and CD68 with positive cells counted.
Result: TL showed an increase in Aβ (P<0.0001), pTau (P<0.0001) and TSPO (P<0.0001) protein load, but not Iba1 or HLA-DR, with progressing Braak stage. Aβ (P = 0.0008) and Iba1 (P = 0.012) load increased in the Cb, but not pTau, TSPO or HLA-DR. Of note, TSPO load in TL was associated with pTau. In both areas, no difference was found in number of HLA+ or CD68+ cells, though TL TSPO+ cell number increased significantly (P = 0.0347). There was no difference in the number of HLA-DR+/TSPO+ or CD68+/TSPO+ cells with progressing Braak stage. However, significantly more CD68+/TSPO+ than HLA-DR+/TSPO+ cells were detected in both the TL (P<0.0001) and Cb (P = 0.009) regions.
Conclusion: the results suggest that TSPO expression is related to late stage disease (pTau) and microglial phagocytosis (CD68), a function we have previously identified associated with the presence of dementia, cognitive decline and tau pathology. Further additional analysis with other microglial markers is currently ongoing.
Text
AAIC 2023 abstract
- Accepted Manuscript
More information
Published date: 25 December 2023
Additional Information:
Poster presentation
Identifiers
Local EPrints ID: 487532
URI: http://eprints.soton.ac.uk/id/eprint/487532
ISSN: 1552-5260
PURE UUID: 8d40f4b1-1fad-48d7-8441-e577ac071bbf
Catalogue record
Date deposited: 22 Feb 2024 18:40
Last modified: 13 Apr 2024 02:01
Export record
Altmetrics
Contributors
Author:
Emma F. Garland
Author:
Laura Kulagowska
Author:
Thomas Scott
Author:
Henrike Antony
Author:
Michel Bottlaender
Corporate Author: et al.
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics